Terms: = Bone cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Treatment
600 results:
1. High incidence of imperforate vagina in ADGRA3-deficient mice.
Kvam JM; Nybo ML; Torz L; Sustarsic RK; Jensen KHR; Nielsen JE; Frederiksen H; Gadgaard S; Spiess K; Poulsen SS; Thomsen JS; Cowin P; Blomberg Jensen M; Kurita T; Rosenkilde MM
BMC Biol; 2024 Apr; 22(1):77. PubMed ID: 38589878
[TBL] [Abstract] [Full Text] [Related]
2. Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies.
Troussard X; Maître E; Paillassa J
Am J Hematol; 2024 Apr; 99(4):679-696. PubMed ID: 38440808
[TBL] [Abstract] [Full Text] [Related]
3. Novel Midkine Inhibitor Induces Cell Cycle Arrest and Apoptosis in Multiple Myeloma.
Cheevapruk K; Ueno M; Sungwan P; Sittithumcharee G; Kariya R; Sampattavanich S; Okada S
Anticancer Res; 2024 Mar; 44(3):1023-1031. PubMed ID: 38423667
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM).
Mill CP; Fiskus WC; DiNardo CD; Reville P; Davis JA; Birdwell CE; Das K; Hou H; Takahashi K; Flores L; Ruan X; Su X; Loghavi S; Khoury JD; Bhalla KN
Blood Cancer J; 2024 Feb; 14(1):25. PubMed ID: 38316746
[TBL] [Abstract] [Full Text] [Related]
5. Network pharmacology and experimental validation to study the potential mechanism of Tongguanteng injection in regulating apoptosis in osteosarcoma.
Wei L; Meng J; Xiang D; Yang Q; Zhou Y; Xu L; Wang M; Chen J; Han Y
BMC Complement Med Ther; 2024 Jan; 24(1):67. PubMed ID: 38297292
[TBL] [Abstract] [Full Text] [Related]
6. Gastric cancer mesenchymal stem cells promote tumor glycolysis and chemoresistance by regulating B7H3 in gastric cancer cells.
Gao Q; Huang C; Liu T; Yang F; Chen Z; Sun L; Zhao Y; Wang M; Luo L; Zhou C; Zhu W
J Cell Biochem; 2024 Mar; 125(3):e30521. PubMed ID: 38226525
[TBL] [Abstract] [Full Text] [Related]
7. Exploration of anti‑osteosarcoma activity of asiatic acid based on network pharmacology and
Pang H; Wu H; Zhan Z; Wu T; Xiang M; Wang Z; Song L; Wei B
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186298
[TBL] [Abstract] [Full Text] [Related]
8. Quality by design fostered fabrication of cabazitaxel loaded pH-responsive Improved nanotherapeutics against prostate cancer.
Shah S; Famta P; Kumar R; Sharma A; Vambhurkar G; Pandey G; Singh G; Kumar P; Mehra A; Mourya A; Srinivasarao DA; Shinde A; Prasad SB; Khatri DK; Madan J; Srivastava S
Colloids Surf B Biointerfaces; 2024 Feb; 234():113732. PubMed ID: 38181691
[TBL] [Abstract] [Full Text] [Related]
9. Inhibitory effects of the nanoscale lysate derived from xenogenic dental pulp stem cells in lung cancer models.
He Y; Li R; She W; Ai Y; Li K; Kumeria T; Jiang Z; Shao Q; Zou C; Albashari AA; Duan X; Ye Q
J Nanobiotechnology; 2023 Dec; 21(1):488. PubMed ID: 38105218
[TBL] [Abstract] [Full Text] [Related]
10. n-3 PUFAs Show Promise as Adjuvants in Chemotherapy, Enhancing their Efficacy while Safeguarding Hematopoiesis and Promoting bone Generation.
Gurav P; Garad S; Nirmala KR
Curr Top Med Chem; 2024; 24(1):45-59. PubMed ID: 37907485
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
12. Neosetophomone B induces apoptosis in multiple myeloma cells via targeting of AKT/SKP2 signaling pathway.
Kuttikrishnan S; Ahmad F; Mateo JM; Prabhu KS; El-Elimat T; Oberlies NH; Pearce CJ; Akil ASA; Bhat AA; Alali FQ; Uddin S
Cell Biol Int; 2024 Feb; 48(2):190-200. PubMed ID: 37885161
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
Huang F; Ruan Y; He X; Lian H; Yang J
World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
[TBL] [Abstract] [Full Text] [Related]
14. Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemia.
Hill BT; Ma S; Zent CS; Baran AM; Wallace DS; Advani A; Winter A; Winter J; Gordan L; Karmali R; Liesveld JL; Mulford DA; Rowland C; Bui A; Sportelli P; Miskin HP; Weiss MS; Friedberg JW; Barr PM
Blood Adv; 2024 Jan; 8(2):378-387. PubMed ID: 37871300
[TBL] [Abstract] [Full Text] [Related]
15. Anti-cancer targets and molecular mechanisms of formononetin in treating osteosarcoma based on network pharmacology.
Chen L; Zhou Y; Weng Z; Liu S; Li T; Wang Y; Yang Y; Liu H; Huang W
Aging (Albany NY); 2023 Oct; 15(20):11489-11507. PubMed ID: 37870753
[TBL] [Abstract] [Full Text] [Related]
16. Multiproperty Polyethylenimine-Caged Platinum Nanoclusters Promote Apoptosis of Osteosarcoma Cells via Regulating the BAX-bcl-2/Caspase-3/PARP Axis.
Wang J; Zhang M; Huang X; Yue H
Mol Pharm; 2023 Nov; 20(11):5607-5615. PubMed ID: 37831437
[TBL] [Abstract] [Full Text] [Related]
17. Dog-bone shaped gold nanoparticle-mediated chemo-photothermal therapy impairs the powerhouse to trigger apoptosis in cancer cells.
Ingle J; Uttam B; Panigrahi R; Khatua S; Basu S
J Mater Chem B; 2023 Oct; 11(40):9732-9741. PubMed ID: 37791575
[TBL] [Abstract] [Full Text] [Related]
18. Chronic lymphocytic leukaemia Australasian consensus practice statement.
Anderson MA; Bennett R; Badoux X; Best G; Chia N; Cochrane T; Cull G; Crassini K; Harrup R; Jackson S; Kuss B; Lasica M; Lew TE; Marlton P; Opat S; Palfreyman E; Polizzotto MN; Ratnasingam S; Seymour JF; Soosapilla A; Talaulikar D; Tam CS; Weinkove R; Wight J; Mulligan SP
Intern Med J; 2023 Sep; 53(9):1678-1691. PubMed ID: 37743239
[TBL] [Abstract] [Full Text] [Related]
19. Constitutively Synergistic Multiagent Drug Formulations Targeting MERTK, FLT3, and bcl-2 for treatment of AML.
Kelvin JM; Jain J; Thapa A; Qui M; Birnbaum LA; Moore SG; Zecca H; Summers RJ; Switchenko JM; Costanza E; Uricoli B; Wang X; Jui NT; Fu H; Du Y; DeRyckere D; Graham DK; Dreaden EC
Pharm Res; 2023 Sep; 40(9):2133-2146. PubMed ID: 37704893
[TBL] [Abstract] [Full Text] [Related]
20. The incidence of translocation t(11;14) among patients with multiple myeloma in a single clinic.
Jew S; Goldwater MS; Bujarski S; Regidor B; Emamy-Sadr M; Swift R; Eades B; Said J; Berenson JR
Am J Clin Pathol; 2024 Jan; 161(1):16-23. PubMed ID: 37611113
[TBL] [Abstract] [Full Text] [Related]
[Next]